An Open, Single-Arm, Phase II Clinical Study Evaluating the Efficacy and Safety of LTC004 Monotherapy in Patients With Metastatic Colorectal Cancer Who Have Failed Third-Line and Above Standard Treatment
Latest Information Update: 29 Apr 2024
At a glance
- Drugs LTC-004 (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Leto Laboratories
Most Recent Events
- 29 Apr 2024 New trial record